QDEL is a strong buy

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.
Why I'm buying right now:
Price target is from low 165.00 to high 341.00
2019 earnings - 72.92 M -> 2020 earnings - 810.29 M = 1111.2 %
Testing is increasing again and we are still above 1 M tests per day
Covid situation in world is indicating third global wave with Europe countries leading it
Fundamental AnalysisTrend Analysis

Disclaimer